SABCS: Younger Postmenopausal Breast Cancer Patients Can Avoid Adjuvant RT

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

THURSDAY, Dec. 7, 2023 -- For postmenopausal women aged 50 to 69 years with stage 1 hormone receptor-positive breast cancer, the risk for recurrence is very low for those who do not undergo radiotherapy after breast-conserving surgery (BCS), according to a study published online Dec. 7 in the Journal of Clinical Oncology to coincide with the annual San Antonio Breast Cancer Symposium, held from Dec. 5 to 9 in San Antonio.

Reshma Jagsi, M.D., D.Phil., from Emory University in Atlanta, and colleagues examined whether younger postmenopausal patients who might be successfully treated without radiotherapy could be identified by adding a genomic assay to classic selection factors. A total of 200 eligible postmenopausal patients aged 50 to 69 years with pT1N0 unifocal invasive breast cancer with margins ≥2 mm after BCS whose tumors were estrogen receptor-positive, progesterone receptor-positive, and HER2-negative, with Oncotype DX 21-gene Recurrence Score ≤18 were enrolled.

One hundred eighty-six patients had clinical follow-up of at least 56 months; at five years, their overall and breast cancer-specific survival rates were both 100 percent. The researchers found that the five-year freedom from recurrence was 99 percent. For the entire follow-up period, the crude rates of ipsilateral breast events were 3.3 and 3.6 percent for patients aged 50 to 59 and 60 to 69 years, respectively; the corresponding crude rates of overall recurrence were 5.0 and 3.6 percent.

"Although techniques of radiation treatment have improved dramatically, and it is far more efficient and tolerable now than it used to be, patients appreciate having a choice about their treatments," Jagsi said in a statement.

Jagsi disclosed ties to the biopharmaceutical industry and reported serving as an expert witness.

Abstract/Full Text

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2023-12-08 06:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords